Cambridge biotech Moderna Inc. is doubling its manufacturing capacity to 3 billion doses of its Covid-19 vaccine in 2022, fueled by new local and international partnerships and an additional $236 million from the U.S. Biomedical Advanced Research and Development Authority.
Read More
